OncoPharm
John Bossaer
Add to My Podcasts
Episodes
About
Reviews
Promote
ESMO 2022 - NICHE-2 and Codebreak 200
11 minutes
Posted Sep 15, 2022 at 7:48 pm.
0:00
11:41
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
ESMO 2022 is wrapped and two studies in particular have caught our eyes:
NICHE-2: neoadjuvant Nivo/Ipi in MMR-d colon cancer
CODEBREAK: sotorasib vs. docetaxel
Previous
Biliary Tract Cancer & Pemigatinib (unrelated) Updates
Next
9 22
← See all 273 episodes of OncoPharm